Literature DB >> 25436078

Antidepressant activity of methanolic extract of amaranthus spinosus.

B S Ashok Kumar1, K Lakshman2, C Velmurugan3, S M Sridhar4, Saran Gopisetty1.   

Abstract

INTRODUCTION: Depressive disorder is a prevalent psychiatric disorder, which affects 21% of the world population. The presently using drugs can impose a variety of side-effects including cardiac toxicity, hypopiesia, sexual dysfunction, body weight gain, and sleep disorder. During the last decade, there is a growing interest in the therapeutic effects of natural products on mental disorders. Amaranthus spinosus was investigation for antidepressant activity.
METHODS: Antidepressant activity of methanolic extract of Amaranthus spinosus (MEAS) was investigated by using Forced swimming test (FST) and Tail suspension test (TST) models. Escitalopram and Imipramine were used as reference standards.
RESULTS: It has been observed from our study that both the MEAS at higher concentration showed significant (p<0.01) reduction in immobility in tail suspension and forced swim model of depression comparable to Escitalopram and Imipramine. DISCUSSION: However further study is needed to understand mechanism of action and to identify active component responsible for antidepressant like activity.

Entities:  

Keywords:  Amaranthus Spinosus; Antidepressant Activity; Escitalopram; Imipramine

Year:  2014        PMID: 25436078      PMCID: PMC4202599     

Source DB:  PubMed          Journal:  Basic Clin Neurosci        ISSN: 2008-126X


1. Introduction

Amaranthus spinosus Linn., (Amaranthaceae), juice was used by tribal of Kerala, India to prevent swelling around stomach while the leaves are boiled without salt and consumed for 2-3 days to cure jaundice (Hema et al., 2006). In Indian traditional system of medicine (Ayurveda) the plant is used as antipyretic, laxative, diuretic, digestive, antidiabetic, anti-snake venum, antileprotic, blood diseases, bronchitis, piles and antigonorrheal (Kirtikar and Basu 1987). The Chinese use A.spinosus as traditional medicine to treat diabetes and seeds used as poultice for broken bones. Some tribes in India apply A. spinosus to induce abortion (Grubben and Denton 2004). A. spinosus is also used as reported to possess antiinflammatory (Olumayokun et al., 2004), antimalarial (Hilou et al., 2006), Antiandrogenic (Murgan et al., 1993b), immunomodulatory (Tatiya et al., 2007), antidiabetic, anti-hyperlipidemic, spermatogenic activities of stem (Sangameswaran and Jayakar, 2008) and effect on hematology (Olufemi et al., 2003) and biochemical changes in Epididymis (Murgan et al., 1993a). The betalains in stem bark of A. spinosus were identified as amaranthin, isoamaranthine, hydroxycinnamates, rutin, quercetin and kaempferol glycosides (Hilou et al., 2006; Ibewuike et al., 1997; Rastogi and Mehrotra, 1999; Stintzing et al., 2004; Ashok Kumar et al., 2008). It also contains amaranthoside, a lignan glycoside, amaricin, a coumaroyl adenosine along with stigmasterol glycoside, betaine such as glycinebetaine and trigonelline (Blunden et al., 1999; Azhar-Ul Haq et al., 2006). Betalains are well known for their antioxidant, anticancer, antiviral and antiparasitosis properties (Kapadia et al., 1995; Kapadia et al., 1996; Patkai et al., 1997). According to the World Health Organization report, mood disorders are the second leading cause worldwide of disability adjusted life years and the leading cause of years lived with disability in all ages. Each drug used to treat this disorder has a success rate of about 60%. In addition, most therapies require several weeks of treatment before improvement of signs and symptoms is observed and there are numerous side effects caused by antidepressants (Wong and Licinio, 2001). Thus, the high prevalence of depression and the fact that a significant proportion of individuals do not respond well to any currently marketed antidepressants or treatments support the need for new therapeutics to treat depression. Numerous antidepressant compounds are now available, presumably acting via different mechanisms including serotonergic, noradrenergic and/or dopaminergic systems (Elhwuegi, 2004). Medical plant therapies may be effective alternatives in the treatment of depression, and has progressed significantly in the past decade (Zhang, 2004). Therefore, the present work aimed to evaluate firstly the antidepressant-like effect of the methanolic extract of Amaranthus spinosus in the models predictive of antidepressant action,

2. Methods

2.1. Collection of Plant Material and Extraction

The fresh plant of A. spinosus was collected from Chickballapur, and was authenticated by Prof. B.K.Venkatesh, Department of Botany, Government First grade College, Chickballapur, Karnataka. A voucher specimen (SKVCP 11) was deposited in college herbarium. The whole plant was shade dried and coarsely powdered. The coarse powder was subjected to extraction with methanol by soxhlet apparatus and extract was concentrated to dryness in vacuum.

2.2. Preliminary Phytochemical Screening

The methanol extract of A.spinosus was screened for the presence of various phytoconstituents like steroids, alkaloids, glycosides, flavonoids, carbohydrates, proteins and phenolic compounds (Kokate, 1986).

2.3. Animals

Male Swiss Wistar rats weighing 150-250 gm were acclimatized to the experimental room at temperature 23 ± 2 °C, controlled humidity conditions (50-55%) and 12 h light and 12 h dark cycle. They were caged with a maximum of two animals in polypropylene cage and were fed with standard food pellets (Kamadenu Enterprises, Bangalore) and water ad libitum. All the studies conducted were approved by the institutional animal ethical committee of Sri K.V.College of Pharmacy, Chickballapur, Karnataka, according to prescribed guidelines of CPCSEA, Government of India (Reg. No. 117/1998/CPCSEA).

2.4. Acute Toxicity Studies

Methanol extract of A. spinosus (was studied for acute oral toxicity as per revised OECD (2002) guidelines No. 423. Animals were observed for four hours hourly for behavior changes and daily for fourteen days. The extract was devoid of any toxicity in rats when given in dose up to 2000 mg/kg by oral route. Hence, for further studies 200-400 mg/kg doses of extract were used.

2.5. Antidepressant Activity

Experimental Design for anti-depressant activity: The rats were divided five groups (n=6). Drugs/ vehicle were administered to the animals 60min prior to study. Group I: Negative control, administer saline 2 ml/kg orally. Group II: Positive control and receive standard drug Escitalopram (10 mg/kg orally). Group III: Receive standard drug Imipramine (10 mg/kg orally) Group IV: Receive MEAS 100 mg/kg orally Group V: Receive MEAS 200 mg/kg orally

2.5.1. Forced Swim Test

For the forced swim test (FST), Rats of either sex were individually forced to swim in an open cylindrical container (diameter 10 cm, height 25 cm) containing 19 cm of water at 25±1°c. Treatment was given 60min prior to study as described by study design. All animals were forced to swim for 6 min and the duration of immobility was observed and measured during the final 4 min interval of the test. Each mouse was judged to be immobile when it ceased struggling and remained floating motionless in the water, making only those movements to keep its head above water. A decrease in the duration of immobility is indicative of an antidepressant like effect (Porsolt et al.. 1977)

2.5.2. Tail Suspension Test

The tail suspension method used in this study was similar to those described by Steru et al., (1985). Treatment was given 60 min prior to study as described by study design. Mice were suspended on the edge of the table, 50 cm above the floor, with the help of adhesive tape placed approximately 1 cm from the tip of the tail. The total duration of immobility induced by tail suspension was recorded during a 6 min of the 10 min period. Animal was considered to be immobile when it did not show any movement of the body, hanged passively and completely motionless.

2.6. Statistical Analysis

All the values were expressed as Mean ± S.E.M. the results were analyzed statistically by one-way ANOVA followed by Dunett Multiple comparison test, P<0.05 was considered significant.

3. Results

3.1. Preliminary Phytochemical Screening

On preliminary phytochemical analysis of MEAS showed the presence of flavonoids, saponins, glycosides, terpenoids amino acids, alkaloids, carbohydrates, phenolic compounds and proteins.

3.2. Acute Toxicity Studies

Methanolic extract of Amaranthus spinosus showed no behavioural changes nor mortality at dose 2000 mg/kg.

3.3. Antidepressant Activity

The antidepressant effects of methanolic extract of Amaranthus spinosus (100 and 200 mg/kg) and Escitalopram and imipramine were studied by observing the changes in the duration of immobility in the two models: Forced swim test (FST) and Tail suspension test (TST). In both TST and FST, MEAS 100 and 200 mg/kg, p.o. produced significant reduction (p<0.01) in the immobility period when compared with that of control group animals that received only the vehicle. The results are tabulated in Table 1.
Table 1

Effect of Amaranthus spinosus on immobility time in Forced swim test and Tail Suspension test

TreatmentDose (mg/Kg)Forced Swim test Duration of Immobility (Sec)Tail Suspension test Duration of Immobility (Sec)
Control140.33±6.6148.5±5.6
Escitalopram460.75±1.38** 90.8±4.59**
Imipramine463.5±1.5** 91±4.56**
MEAS10048±2.58** 106.4±3.2**
MEAS20059.6±1.310** 114.3±3.5**

Each value represents Mean ± S.E.M., n=6.

p< 0.05 compared with control.

Effect of Amaranthus spinosus on immobility time in Forced swim test and Tail Suspension test Each value represents Mean ± S.E.M., n=6. p< 0.05 compared with control.

4. Discussion

Depression is an important psychiatric disorder that affects individuals’ quality of life and social relations directly. Depression is characterized by emotional symptoms such ashopelessness, apathy, loss of selfconfidence, sense of guilt, indecisiveness, and amotivation, as well as biological symptoms like psychomotor retardation, loss of libido, sleep disturbances, and loss of appetite. When the symptoms are very severe, major depression is considered. Medications such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), selective reversible inhibitors of monoamine oxidase A (RIMAs), and specific serotoninnoradrenaline reuptake inhibitors (SNRIs) are clinically employed for drug therapy (Fava, 2003). However, these drugs can impose a variety of side-effects including cardiac toxicity, hypopiesia, sexual dysfunction, body weight gain, and sleep disorder (Antai-Otong, 2004; Baldwin et al., 2006; Khurana and Baudendistel, 2003; Park et al., 2005). Escitalopram is classical selective serotonin reuptake inhibitors SSRIs, it is bound at the primary site of presynaptic serotonin transporter (SERT) with a very high affinity, and it has higher serotonergic activity than the classical SSRIs (Sanchez et al., 2004). Imipramine prevents reuptake of nor adrenaline and serotonin resulting in their increased availability in the synapse and therefore an increase in adrenergic and serotonergic neurotransmission (Tatsumi et al., 1997). In this study, we used two animal models, FST and TST. Both the paradigms are widely accepted behavioral models for assessing pharmacological antidepressant activity (Bourin, 1990; Porsolt et al., 1977). Characteristic behavior scored in these tests is termed immobility, reflecting behavioral despair as seen in human depression (Steru et al., 1985; Willner, 1984). In addition, it is well known that many antidepressant drugs are able to reduce the immobility time in rodents (Porsolt et al., 1977). MEAS produced a marked reduction in immobility time at doses of 100 and 200 mg/kg in the rat FST and TST, with a profile comparable to that observed for the classical antidepressant drug ESC and imipramine. FST has not traditionally been viewed as a consistently sensitive model for detecting selective serotonin reuptake inhibitor activity, whereas these antidepressants are generally reported as active in the TST (Cryan et al., 2005). Moreover, TST is proposed to have a greater pharmacological sensitivity as compared with FST (Cryan et al., 2005; Thierry et al., 1986). A. spinosus, contains amino acids namely, lysine, arginine, histidine, cystine, phenylalanine, leucine, isoleucine, valine, threonine, methionine, tyrosine and tryptophan (Anonymous, 1988). These amino acids contribute positively to the antioxidant activity (Hernandez-Ledesma et al., 2005; Chen et al., 1998; Saito et al., 2003; Chen et al., 1996; Cameron & Pauling 1979). Amaranthus also reported to contain beta-carotene, thiamine, riboflavin, niacin and ascorbic acid. Carotenoids serve as precursors of vitamin A, show antioxidant activity (De Pee et al., 1995). Phytochemical analysis showed the presence of Flavonoids and phenolic compounds have been reported to have multiple biological effects such as Central nervous system disorders (Priyanka et al., 2012), antioxidant activity (Bors & Saran, 1987), analgesic (Mills & Bone, 2000), anti-inflammatory (Lilian Eugenia Peizer et al., 1998), inhibition of mast cell histamine release antiulcerogenic (Van Wauve & Goosens, 1989), cytotoxic, antihypertensive, hypolipidemic, antiplatelet and neurodegenerative diseases (Amresh et al., 2007). A study from Noldner and Schotz (2002) has indicated that rutin is essential for the antidepressant activity of Hypericum perforatum extract, a plant used in many countries for the treatment of mild to moderate forms of depression (Linde and Knüppel, 2005),

Conclusion

The present study provides the first evidence indicating that methanolic extract of Amaranthus spinosus showed significant antidepressant activity in TST and FST models of depression. Further research is required to know the mechanism of its action.
General procedure of qualitative chemical tests
S.No.Chemical testsObservationInference
1.a) Test for Carbohydrates Molisch's test (General Test) To the 2 to 3 ml extract, few drops of α-Napthol solution in alcohol was added followed by addition of conc.H2SO4 from the sides of the test tube.Violet ring is formed at the junction of two liquidsPresence of Carbohydrates
b) Fehling's Test 1 ml. of Fehling's A and 1 ml Fehling's B was mixed in the test tube. Equal volume of extract was added and heated in the boiling water bath for 5-10 min.First yellow, then brick red precipitate is ObservedPresence of reducing Sugars
c) Benedict's Test Equal volume of Benedict's reagent and extract in the test tube was added and heated in a boiling water bath.Solution appears green, yellow or redPresence of Reducing sugars
d) Barfoed's Test Equal volume of Barfoed's reagent and extract was mixed and heated for 1-2 min. in boiling water and cool.Red precipitate is observedPresence of Monosaccharides
2. Test for Proteins and aminoacids Biuret Test To 3 ml of extract 4% NaOH and few drops of 1% CuSO4 Solution was added.Violet or Pink colour developsPresence of Proteins
Ninhydrin Test 3 ml extract and 3 drops of Ninhydrin solution was heated in boiling water bath for 10 min.Purple or bluish colour appearsPresence of Amino acids
3.a) Test for Fats and Fixed Oils A small quantity of extract was pressed between filter papers.Oil stains on the paperPresence of fixed Oils
4.a) Test For Steroid Liebermann-Burchard reaction 2 ml of the extract was mixed with chloroform and 1-2 ml acetic anhydride and 2 drops of Conc. H2SO4 was added through the sides of the test tube.Purple ring with acid solution turning greenPresence of Steroid
5.a) Test For Glycosides Cardiac Glycosides Keller Kiliani test To 2 ml extract, glacial acetic acid, one drop of FeCl3 and Conc. H2SO4 was addedReddish brown layer appears at the junction of two liquidsPresence of Cardiac Glycosides
b) Legal's Test: The extracts were treated with sodium nitroprusside in pyri-dine and methanolic alkali. The formation ofpink to red colorPresence of cardiac glycosides.
c) Anthraquinone glycosides Borntrager's test To the extract dil. H2SO4 was added. The mixture was boiled and then filtered. To the cold filtrate, equal volume of benzene or chloroform was added. It was then shaked well. The organic solvent was separated and ammonia was added.Ammoniacal layer turns pink or redPresence of Anthraquinone glycosides
d) Saponin glycoside Foam test The drug powder or the extract was shaken vigorously with water.Persistent foam is observedPresence of Saponin glycosides
6. Test for Phenolic Compounds and tannins To the extract FeCl3 was added.Deep blue-black colour formedPresence of Phenolic Compounds
7.a) Test for Flavonoids Shinoda Test To the extract, 0.5g of magnesium turnings and few drops of Conc.HCl were added from the sides of the test tube.Pink colour observedPresence of Flavonoids
8.a) Test for Alkaloids Dragendroff's test To the filtrate few drops of dragendroff's reagent was added.Orange brown ppt. is formed.Presence of Alkaloids.
  31 in total

Review 1.  Diagnosis and definition of treatment-resistant depression.

Authors:  Maurizio Fava
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

2.  Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.

Authors:  David Baldwin; Kevin Bridgman; Christel Buis
Journal:  J Psychopharmacol       Date:  2005-10-04       Impact factor: 4.153

Review 3.  Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?

Authors:  M Bourin
Journal:  Fundam Clin Pharmacol       Date:  1990       Impact factor: 2.748

4.  Decomposition of anticarcinogen factors of the beetroot during juice and nectar production.

Authors:  G Pátkai; J Barta; I Varsányi
Journal:  Cancer Lett       Date:  1997-03-19       Impact factor: 8.679

5.  The tail suspension test: ethical considerations.

Authors:  B Thierry; L Stéru; P Simon; R D Porsolt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 6.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Interaction between cardiac calsequestrin and drugs with known cardiotoxicity.

Authors:  Il Yeong Park; Eun Jung Kim; HaJeung Park; Kelly Fields; A Keith Dunker; ChulHee Kang
Journal:  Mol Pharmacol       Date:  2004-10-18       Impact factor: 4.436

8.  Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test.

Authors:  Michael Nöldner; Karl Schötz
Journal:  Planta Med       Date:  2002-07       Impact factor: 3.352

9.  Betacyanins and phenolic compounds from Amaranthus spinosus L. and Boerhavia erecta L.

Authors:  Florian C Stintzing; Dietmar Kammerer; Andreas Schieber; Hilou Adama; Odile G Nacoulma; Reinhold Carle
Journal:  Z Naturforsch C J Biosci       Date:  2004 Jan-Feb

10.  Acute and chronic antiinflammatory effects of plant flavonoids.

Authors:  L E Pelzer; T Guardia; A Osvaldo Juarez; E Guerreiro
Journal:  Farmaco       Date:  1998-06-30
View more
  6 in total

1.  Colorant Pigments, Nutrients, Bioactive Components, and Antiradical Potential of Danta Leaves (Amaranthus lividus).

Authors:  Umakanta Sarker; Md Asif Iqbal; Md Nazmul Hossain; Shinya Oba; Sezai Ercisli; Crina Carmen Muresan; Romina Alina Marc
Journal:  Antioxidants (Basel)       Date:  2022-06-20

Review 2.  Application of HPLC and ESI-MS techniques in the analysis of phenolic acids and flavonoids from green leafy vegetables (GLVs).

Authors:  B Ramesh Kumar
Journal:  J Pharm Anal       Date:  2017-06-16

3.  In Vivo Psychopharmacological Investigation of Delphinium Denudatum and Amaranthus Spinosus Extracts on Wistar Rats.

Authors:  Mohammad Abid; Ashok Kumar Gosh; Najam Ali Khan
Journal:  Basic Clin Neurosci       Date:  2017 Nov-Dec

Review 4.  The Dual Nature of Amaranth-Functional Food and Potential Medicine.

Authors:  Justyna Baraniak; Małgorzata Kania-Dobrowolska
Journal:  Foods       Date:  2022-02-21

5.  A Novel Tetraenoic Fatty Acid Isolated from Amaranthus spinosus Inhibits Proliferation and Induces Apoptosis of Human Liver Cancer Cells.

Authors:  Arijit Mondal; Tanmoy Guria; Tapan Kumar Maity; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

6.  Experimental evaluation of anti-inflammatory, antinociceptive and antipyretic activities of clove oil in mice.

Authors:  Yousef A Taher; Awatef M Samud; Fathy E El-Taher; Ghazala ben-Hussin; Jamal S Elmezogi; Badryia F Al-Mehdawi; Hanan A Salem
Journal:  Libyan J Med       Date:  2015-09-01       Impact factor: 1.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.